ATE548364T1 - Aminopyrazolkinasehemmer - Google Patents
AminopyrazolkinasehemmerInfo
- Publication number
- ATE548364T1 ATE548364T1 AT08705673T AT08705673T ATE548364T1 AT E548364 T1 ATE548364 T1 AT E548364T1 AT 08705673 T AT08705673 T AT 08705673T AT 08705673 T AT08705673 T AT 08705673T AT E548364 T1 ATE548364 T1 AT E548364T1
- Authority
- AT
- Austria
- Prior art keywords
- aminopyrazole
- kinase inhibitors
- formula
- useful
- pharmaceutically acceptable
- Prior art date
Links
- JVVRJMXHNUAPHW-UHFFFAOYSA-N 1h-pyrazol-5-amine Chemical compound NC=1C=CNN=1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 title 1
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88360107P | 2007-01-05 | 2007-01-05 | |
| PCT/US2008/050157 WO2008086128A2 (en) | 2007-01-05 | 2008-01-04 | Aminopyrazole kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE548364T1 true ATE548364T1 (de) | 2012-03-15 |
Family
ID=39493124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08705673T ATE548364T1 (de) | 2007-01-05 | 2008-01-04 | Aminopyrazolkinasehemmer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7851500B2 (enExample) |
| EP (1) | EP2111402B1 (enExample) |
| JP (1) | JP5286281B2 (enExample) |
| CN (1) | CN101627027B (enExample) |
| AT (1) | ATE548364T1 (enExample) |
| WO (1) | WO2008086128A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2145021A2 (en) | 2007-05-17 | 2010-01-20 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators |
| ES2670601T3 (es) * | 2012-05-15 | 2018-05-31 | Novartis Ag | Derivados de benzamida para la inhibición de la actividad de ABL1, ABL2 y BCR-ABL1 |
| CN105418616B (zh) * | 2015-12-26 | 2018-01-12 | 山东大学 | 一种含有 4‑氨基吡唑结构的jak 激酶抑制剂及其制备方法和应用 |
| US20240158391A1 (en) * | 2019-10-15 | 2024-05-16 | Aucentra Therapeutics Pty Ltd | Derivatives of 4-(imidazo[1,2-a]pyridin-3-yl)-n-(pyridin-3-yl) pyrimidin-2- amine for treating proliferative diseases and conditions |
| AU2023216263A1 (en) * | 2022-02-04 | 2024-08-22 | Mrja Therapeutics, Inc. | Certain chemical entities, compositions, and methods |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL144977A0 (en) * | 1999-05-21 | 2002-06-30 | Bristol Myers Squibb Co | Pyrrolotriazine derivatives and pharmaceutical compositions containing the same |
| HN2001000008A (es) * | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
| ES2257461T3 (es) * | 2000-12-21 | 2006-08-01 | Bristol-Myers Squibb Company | Inhibidores de tiazolilo de tirosina quinasas de la familia tec. |
| TW200401638A (en) * | 2002-06-20 | 2004-02-01 | Bristol Myers Squibb Co | Heterocyclic inhibitors of kinases |
| TWI329112B (en) * | 2002-07-19 | 2010-08-21 | Bristol Myers Squibb Co | Novel inhibitors of kinases |
-
2008
- 2008-01-04 EP EP08705673A patent/EP2111402B1/en not_active Not-in-force
- 2008-01-04 AT AT08705673T patent/ATE548364T1/de active
- 2008-01-04 JP JP2009544979A patent/JP5286281B2/ja not_active Expired - Fee Related
- 2008-01-04 US US12/521,061 patent/US7851500B2/en active Active
- 2008-01-04 WO PCT/US2008/050157 patent/WO2008086128A2/en not_active Ceased
- 2008-01-04 CN CN2008800073289A patent/CN101627027B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2111402B1 (en) | 2012-03-07 |
| JP2010515688A (ja) | 2010-05-13 |
| US7851500B2 (en) | 2010-12-14 |
| EP2111402A2 (en) | 2009-10-28 |
| US20100022503A1 (en) | 2010-01-28 |
| CN101627027B (zh) | 2013-06-19 |
| WO2008086128A3 (en) | 2008-09-25 |
| WO2008086128A2 (en) | 2008-07-17 |
| CN101627027A (zh) | 2010-01-13 |
| JP5286281B2 (ja) | 2013-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201300109B (it) | Imidazopiridazincarbonitrili utili come inibitori di chinasi | |
| SG178591A1 (en) | Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer | |
| EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
| PH12015500064A1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
| DK1761520T3 (da) | Kinaseinhibitorer | |
| EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
| MY148322A (en) | Substituted 2-alkyl quinazolinone derivatives as parp inhibitors | |
| NI201000059A (es) | Inhibidores de la cinasa c-fms. | |
| MX2010009207A (es) | Compuestos y composiciones heterociclicos como inhibidores de c-kit y pdgfr cinasa. | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| NI200900021A (es) | Inhibidor de quinasa | |
| EA201200049A1 (ru) | 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17 | |
| PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
| DK2134691T3 (da) | Quinolinonderivativer som parp- og tank-inhibitorer | |
| EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| MY169515A (en) | Quinazolinedione derivatives as parp inhibitors | |
| UA99617C2 (ru) | Производные пирролконденсированного азотсодержащего гетероцикла, их получение и фармацевтическое применение | |
| EA201170680A1 (ru) | Ингибиторы акт и p70 s6-киназы | |
| MY155719A (en) | 2-benzylpyridazinone derivatives as met kinase inhibitors | |
| EA201071224A1 (ru) | Ингибиторы limk2, композиции, содержащие их, и способы их применения | |
| ATE542800T1 (de) | Kinasehemmer und ihre anwendungsverfahren | |
| EA200900631A1 (ru) | Замещённые пиразолы и триазолы, как ингибиторы кбв (кинезин-белок веретена) | |
| EA200801199A1 (ru) | Ингибиторы киназы | |
| UA85505C2 (en) | Kinase inhibitors | |
| WO2008086128A3 (en) | Aminopyrazole kinase inhibitors |